Aegion (AEGN) Stock Rating Lowered by ValuEngine

Aegion (NASDAQ:AEGN) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Thursday.

Several other equities research analysts also recently commented on AEGN. Zacks Investment Research downgraded Aegion from a “hold” rating to a “sell” rating in a report on Wednesday, February 7th. BidaskClub raised Aegion from a “hold” rating to a “buy” rating in a report on Friday, April 6th. Hilliard Lyons downgraded Aegion from a “buy” rating to a “neutral” rating in a report on Thursday, December 21st. Finally, DA Davidson reaffirmed a “neutral” rating on shares of Aegion in a report on Thursday, March 1st. Seven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Aegion currently has an average rating of “Hold” and a consensus target price of $26.75.

NASDAQ AEGN opened at $23.11 on Thursday. The company has a market capitalization of $787.46, a PE ratio of 22.44, a P/E/G ratio of 1.42 and a beta of 1.70. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.24 and a quick ratio of 2.00. Aegion has a 12 month low of $19.11 and a 12 month high of $28.19.

Aegion (NASDAQ:AEGN) last released its quarterly earnings data on Wednesday, February 28th. The construction company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.03). The company had revenue of $337.50 million during the quarter, compared to analyst estimates of $332.50 million. Aegion had a negative net margin of 5.37% and a positive return on equity of 6.32%. sell-side analysts forecast that Aegion will post 1.36 earnings per share for the current year.

In other Aegion news, CAO Michael D. White sold 4,141 shares of the firm’s stock in a transaction on Monday, March 12th. The stock was sold at an average price of $23.36, for a total transaction of $96,733.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Charles R. Gordon sold 20,000 shares of the stock in a transaction on Monday, March 12th. The stock was sold at an average price of $23.36, for a total value of $467,200.00. Following the transaction, the chief executive officer now owns 306,802 shares in the company, valued at approximately $7,166,894.72. The disclosure for this sale can be found here. Company insiders own 3.37% of the company’s stock.

Hedge funds have recently bought and sold shares of the business. BlackRock Inc. increased its position in Aegion by 2.3% during the 4th quarter. BlackRock Inc. now owns 4,360,885 shares of the construction company’s stock worth $110,898,000 after buying an additional 99,315 shares during the period. Alambic Investment Management L.P. increased its position in Aegion by 97.8% during the 4th quarter. Alambic Investment Management L.P. now owns 138,912 shares of the construction company’s stock worth $3,533,000 after buying an additional 68,680 shares during the period. KBC Group NV increased its position in Aegion by 22.2% during the 4th quarter. KBC Group NV now owns 170,495 shares of the construction company’s stock worth $4,336,000 after buying an additional 30,924 shares during the period. Ameriprise Financial Inc. increased its position in Aegion by 20.3% during the 3rd quarter. Ameriprise Financial Inc. now owns 267,673 shares of the construction company’s stock worth $6,231,000 after buying an additional 45,130 shares during the period. Finally, Rhumbline Advisers increased its position in Aegion by 15.4% during the 4th quarter. Rhumbline Advisers now owns 80,079 shares of the construction company’s stock worth $2,036,000 after buying an additional 10,680 shares during the period. Hedge funds and other institutional investors own 93.94% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was posted by Ticker Report and is the property of of Ticker Report. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/3375699/aegion-aegn-stock-rating-lowered-by-valuengine.html.

Aegion Company Profile

Aegion Corporation (Aegion) is engaged in providing infrastructure protection and maintenance. The Company operates through three segments: Infrastructure Solutions, Corrosion Protection and Energy Services. The Company offers service solutions, including rehabilitation of water and wastewater pipelines with Insituform cured-in-place pipe (CIPP) products; fusible polyvinyl chloride products for rehabilitation; fiber reinforced polymer systems for rehabilitation and strengthening; cathodic protection for corrosion engineering control and infrastructure rehabilitation; pipe coatings for corrosion control and prevention; high density polyethylene (HDPE) pipe lining for corrosion control, abrasion protection and pipeline rehabilitation, and construction and maintenance of oil and gas facilities.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Aegion (NASDAQ:AEGN)

Receive News & Ratings for Aegion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aegion and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Reliance Steel & Aluminum Co  Director Mark V. Kaminski Sells 8,200 Shares
Reliance Steel & Aluminum Co Director Mark V. Kaminski Sells 8,200 Shares
Copico  Hits 24 Hour Trading Volume of $1,269.00
Copico Hits 24 Hour Trading Volume of $1,269.00
Zacks: Liberty Broadband Corp Series C  Receives Consensus Recommendation of “Hold” from Analysts
Zacks: Liberty Broadband Corp Series C Receives Consensus Recommendation of “Hold” from Analysts
BatCoin  Trading 1.2% Lower  Over Last Week
BatCoin Trading 1.2% Lower Over Last Week
Happycoin Price Up 6.2% Over Last Week
Happycoin Price Up 6.2% Over Last Week
Pacific Biosciences  and PerkinElmer  Head-To-Head Analysis
Pacific Biosciences and PerkinElmer Head-To-Head Analysis


© 2006-2018 Ticker Report. Google+.